vania-janet/multiturn-rag-retrieval-data huggingface dataset:
Understanding Respiratory Illnesses - RSV, Flu, and COVID-19
All New Yorkers, especially parents and guardians of young children, should understand the common respiratory illnesses that typically spread during fall and winter, and how to protect themselves and their families.
Learn about the seasonal flu, RSV, and COVID-19 including how each virus presents, spreads, symptoms, and what to do following exposure. Most importantly, learn how to prevent infections, and make sure that you and your children are up to date with flu and COVID-19 shots.

Updated CDC Respiratory Virus Guidance:

https://www.cdc.gov/respiratory-viruses/guidance/respiratory-virus-guidance.html

Updated CDC Recommendations Press Release:

https://www.cdc.gov/media/releases/2024/p0301-respiratory-virus.html

What to Know About Contagious Respiratory Illnesses

 
Flu
Respiratory Syncytial Virus (RSV)
COVID-19

Overview
Most people – including children – will recover from the flu on their own, but some people will experience severe illness requiring hospitalization.
Respiratory Syncytial Virus (RSV) infection can cause severe infection in some people, including babies 12 months and younger, especially premature babies, seniors, people with heart and lung disease, or anyone with a weak immune system (immunocompromised).In adults and older, healthy children, RSV symptoms are mild and typically mimic the common cold. Self-care measures are usually all that's needed to relieve any discomfort.
COVID-19 can cause severe infection in some people, including children, and can lead to hospitalization and even death. People who have received COVID-19 vaccines can still experience infections, although their risk of severe illness and hospitalization is greatly reduced.

Time from exposure to infection
2 to 3 days
1 to 4 days
2 to 14 days

Prevention

Get immunized
Wash your hands often
Avoid people who are sick
Wear a mask in crowded places

Get immunized if eligible
Wash your hands often
Avoid people who are sick
Wear a mask in crowded places

Get immunized – including updated vaccine
Wash your hands
Avoid people who are sick
Mga Bakuna Sa COVID-19 Sa VA | Veterans Affairs
Makuha ang mga pinakabagong update ukol sa kung paano maaapektuhan ng pandemyang COVID-19 ang inyong mga benepisyo at serbisyo.

Bisitahin ang inyong lokal na medical center website ng VA para madagdagan ang nalalaman tungkol sa paghahanda para sa bakuna sa COVID-19.

Magbasa pa tungkol sa aming tugon sa pampublikong kalusugan sa pandemyang COVID-19.

Bilang isa sa mga nangunguna sa pangkalusugang pagsasaliksik sa bansa, nagsisikap kaming makapagpatuloy upang humanap ng mga paraan para mapigilan at gamutin ang COVID-19. Alamin kung paano kayo makikibahagi sa mga pagsisikap na ito at kung ano ang mga dapat asahan kung kayo ay magboboluntaryo.

Simulan ang iyong aplikasyon para sa pangangalaga ng kalusugan sa VA ngayon.

Alamin kung paano kumuha ng mga diagnostic lab na pagsusuri para sa COVID-19 at mga self-test kit sa pamamagitan ng VA.

Last updated: March 18, 2024

Feedback
Information for Providers | Department of Health
AvailabilityHHS has created two resources to assist providers: A COVID-19 Therapeutics Locator which can be used to find locations with available Paxlovid or Molnupiravir. A Medication Locator which can be used to find Test to Treat locations and pharmacies to fill COVID-19 prescriptions. If you are within New York City, please refer to: COVID-19: Outpatient Therapeutic Information for Providers - NYC Health Patients will require a prescription for Paxlovid and molnupiravir (Lagevrio). ContactPlease contact the COVID-19 Therapeutics team at [email protected] if you have any questions and/or concerns. 

 Monoclonal Antibody (mAb) Therapeutics
 
 
 

Beginning in September 2021, the New York State Department of Health (Department) began managing the distribution process for monoclonal antibody (mAb) therapeutics within the State. There is no product currently available. There are some products that were previously distributed but are not currently authorized for use in New York. These products are:  Bamlanivimab/etesevimab (Lilly)Etesevimab (Lilly – to pair with bamlanivimab already on hand) Casirivimab/imdevimab, i.e., REGEN-COV (Regeneron)Sotrovimab (GlaxoSmithKline)Bebtelovimab (Lilly)EvusheldPlease see the Oral Antivirals section for available treatments.

 Vaccine Resources
 
 
 

NYS Local Health Department Directory CDC COVID-19 Vaccine website   

 Guidance
 
 
 

Find current and archived COVID-19 guidance documents released by New York State since the start of the pandemic.COVID-19 GUIDANCE DOCUMENTS

 Additional Information
 
 
 

Create a Health Commerce AccountAll healthcare providers should have a Health Commerce Account. Create an account here.Community ProgramsNew York State Public Health CorpsNew York State is seeking public health professionals to build public health capacity to increase preparedness for future health emergencies.Health Care Provider Reserve WorkforceLicensed health care professionals are encouraged to register as a volunteer with ServNY to help with the State's response to a future public health emergency. 

 COVID-19

Accessibility

Centers for Disease Control and Prevention
COVID-19 Overview and Infection Prevention and Control Priorities in non-U.S. Healthcare Settings | CDC
Coronaviruses are a large family of viruses that can cause illness in animals or humans. In humans there are several known coronaviruses that cause respiratory infections. These coronaviruses range from the common cold to more severe diseases such as severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), and COVID-19.
Top of PageCoronavirus Disease 2019:
Emergence
COVID-19 was identified in Wuhan, China in December 2019. COVID-19 is caused by the virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a new virus in humans causing respiratory illness which can be spread from person-to-person. Early in the outbreak, many patients were reported to have a link to a large seafood and live animal market; however, later cases with no link to the market confirmed person-to-person transmission of the disease. Additionally, travel-related exportation of cases occurred.
Transmission
There are three main ways that COVID-19 can spread:

By breathing in air carrying droplets or aerosol particles that contain the SARS-CoV-2 virus when close to an infected person or in poorly ventilated spaces with infected persons
By having droplets and particles that contain the SARS-CoV-2 virus land on the eyes, nose, or mouth – especially through splashes and sprays like a cough or sneeze
By touching the eyes, nose, or mouth with hands that have the SARS-CoV-2 virus particles on them

The droplets that contain the SARS-CoV-2 virus are released when someone with COVID-19 sneezes, coughs, or talks. Infectious droplets can land in the mouths or noses of people who are nearby or possibly be inhaled into the lungs. A physical distance of at least 1 meter (3 ft) between persons is recommended by the WHO to avoid infection,1 whereas CDC recommends maintaining a physical distance of at least 1.8 meters (6ft) between persons.
Covid-19 Vaccines


<br></p></li><li><p><span class="ui-provider fo b c d e f g h i j k l m n o p q r s t u v w x y z ab ac ae af ag ah ai aj ak" dir="ltr"><a aria-label="Link Data-Use-and-Sharing-Agreement-FAQ" title="https://author.cdph.ca.gov/programs/cid/dcdc/pages/covid-19/data-use-and-sharing-agreement-faq.aspx" href="/Programs/CID/DCDC/Pages/COVID-19/Data-Use-and-Sharing-Agreement-FAQ.aspx" rel="noreferrer noopener" target="_blank" class="fui-Link ___10kug0w f3rmtva f1ewtqcl fyind8e f1k6fduh f1w7gpdv fk6fouc fjoy568 figsok6 f1hu3pq6 f11qmguv f
Covid-19 Vaccines


<span class="ms-rteThemeFontFace-1 ms-rteFontSize-3"></span></p><p></p>Archived Learn More About Vaccines199Archived Learn More About Vaccines<ul><li><p><a href="/Programs/CID/DCDC/Pages/COVID-19/Allocation-Guidelines-COVID-19-Vaccine-Phase-1A.aspx">Allocation Guidelines for COVID-19 Vaccine During Phase 1A</a> 12/14/2020​<br></p></li><li><p>​​<a href="/Programs/CID/DCDC/Pages/COVID-19/Breastfeeding-Guidance.aspx">Breastfeeding Guidance During the COVID-19 Pandemic</a> 8/15/2022​<br></p></li><li><p><span class="ms-rteFontSize-2" style="font-family:calibri, sans-serif;"><a href="/Programs/CID/DCDC/Pages/COVID-19/California-Data-Use-Agreement.aspx">California ​​​Data Use Agreement</a> 12/16/2020</span><br></p></li><li><p><a href="/Programs/CID/DCDC/Pages/COVID-19/COVID-19Vaccine.aspx" title="California's Vaccination Plan">California's Vaccination Plan</a> 4/21/2021<br></p></li><li><p><a href="/Programs/CID/DCDC/Pages/COVID-19/CDPH-Allocation-Guidelines-for-COVID-19-Vaccine-During-Phase-1A-Recommendations.aspx">CDPH Allocation Guidelines for COVID-19 Vaccine During Phase 1A Recommendation</a> 12/05/2020​​<br></p></
Consortium on Long COVID - February 3, 2022 | Department of Health
Through important discussions on the research, clinical, and policy/regulatory considerations for long COVID, experts from across US will provide recommendations to better understand, treat, and ultimately prevent long COVID.
This consortium will feature three separate panel discussions throughout the day. The event schedule is below:

8:45 am – 9:00 am: Introduction from State Health Commissioner Dr. Mary T. Bassett
9:00 am – 10:30 am: A premier research panel who will further define what is currently known including epidemiological aspects of the condition, biological causes, groups most severely affected, and current research efforts.
11:00 am – 12:30 pm: An expert clinical care panel will discuss the various clinical manifestations and presentations of long COVID, risk factors, and treatment guidelines in various populations and settings across age, race/ethnicity, and geography.
1:00 pm – 2:30 pm: A integrated panel focusing on policy and functional outcomes will provide recommendations for policies, programs, and initiatives that NYS can use as a framework to address long COVID and aid in the physical, social, and psychological recovery of individuals impacted by long COVID.

 
Panelists and Moderators
 
Research Panel:

Jennifer Frontera, MD - Professor of Neurology, New York University Grossman School of Medicine
Mady Hornig, MA, MD - Associate Professor of Epidemiology, Columbia University Mailman School of Public Health
Lawrence Purpura, MD, MPH & TM - Instructor of Medicine, Division of Infectious Diseases, Columbia University Irving Medical Center
Akiko Iwasaki, PhD - Waldemar Von Zedtwitz Professor of Immunobiology and Molecular, Cellular, and Developmental Biology, Yale University
Michael Roehrl, MD, PhD - Director, Precision Pathology Center, Memorial Sloan Kettering Cancer Center
Moderated by: Eli Rosenberg, PhD – Deputy Director for Science, Office of Public Health, New York State Department of Health

 
Clinical Panel:

Benjamin Abramoff, MD, MS - Director, Spinal Cord Injury Program; Assistant Professor of Clinical Physical Medicine and Rehabilitation, Penn Medicine
Abigail Chua, MD, MPH - Clinical Assistant Professor of Medicine, Division of Pulmonary, Clinical Care and Sleep Medicine, Stony Brook University Hospital
Multiple Sclerosis Centers of Excellence Home
For Veterans with MS, MSCoE recommends following guidance from the National MS Society, Centers for Disease Control, and VA regarding prevention and treatment of COVID-19. Use the following links to access information.

Centers for Disease Control: COVID-19 Vaccines and Boosters
National MS Society: MS and COVID-19
VA: COVID-19 Vaccines at VA
VA: COVID-19 Vaccine in Veterans with MS: Protect the Vulnerable
VA: Novel Coronavirus Disease (COVID-19)
World Health Organization: Coronavirus Disease (COVID-19) Pandemic

Resources

VA Health Benefits
VA Aid and Attendance
VA Home and Community Based Care

VA My Healthevet
VA Rehabilitation and Prosthetics

VA Office of Community Care
VA Caregiver Support

CONNECT

 Veterans Crisis Line:
Call: 988 (Press 1)
Social Media

Complete Directory 

EMAIL UPDATES

Email Address Required

Button to subscribe to email

VA HOME

Notices
Privacy
FOIA
Regulations
Web Policies
No FEAR Act
Whistleblower Rights & Protections
Site Index
USA.gov
White House
Inspector General

QUICK LIST

Apply for Benefits
Apply for Health Care
Prescriptions
My HealtheVet
Life Insurance Online Applications
VA Forms
State and Local Resources
Strat Plan FY 2014-2020 
VA Plans, Budget, & Performance
VA Claims Representation

RESOURCES

Careers at VA
Employment Center
Returning Service Members
Vocational Rehabilitation & Employment
Homeless Veterans
Women Veterans
Minority Veterans
Plain Language
Surviving Spouses & Dependents
Adaptive Sports Program

ADMINISTRATION

Veterans Health Administration
Veterans Benefits Administration
National Cemetery Administration

U.S. Department of Veterans Affairs | 810 Vermont Avenue, NW Washington DC 20420
Last updated May 22, 2024

Get help from Veterans Crisis Line

 Call 988 (Press 1)
 Text to 838255
 Chat confidentially now
 Call TTY if you
 have hearing loss 1-800-799-4889
Consortium on Long COVID - February 3, 2022 | Department of Health
Michael Roehrl, MD, PhD - Director, Precision Pathology Center, Memorial Sloan Kettering Cancer Center
Moderated by: Eli Rosenberg, PhD – Deputy Director for Science, Office of Public Health, New York State Department of Health

 
Clinical Panel:

Benjamin Abramoff, MD, MS - Director, Spinal Cord Injury Program; Assistant Professor of Clinical Physical Medicine and Rehabilitation, Penn Medicine
Abigail Chua, MD, MPH - Clinical Assistant Professor of Medicine, Division of Pulmonary, Clinical Care and Sleep Medicine, Stony Brook University Hospital
John Baratta, MD, MBA - Clinical Assistant Professor & Medical Director of Stroke Rehabilitation, Department of Physical Medicine and Rehabilitation, University of North Carolina-Chapel Hill
Ixsy Ramirez, MD, MPH - Assistant Professor of Pediatrics, University of Michigan Medical School
Sharagim Kemp, DO - Medical Director, Nuvance Health COVID Recovery Program
Zijian Chen, MD - Medical Director, Center for Post-COVID Care, Mount Sinai
Sarah J. Ryan, MD - Assistant Professor of Medicine, Columbia University Irving Medical Center
Moderated by: Emily Lutterloh, MD, MPH – Director, Division of Epidemiology, New York State Department of Health

 
Policy/Functional Panel:

Diana Berrent - Founder, Survivor Corps
David Putrino, PT, PhD - Director of Rehabilitation Innovation, Mount Sinai
Karen Costley-Hoke, MD, MPH - Medical Director and Assistant Vice President, Healthfirst
Monica Lypson, MD, MHPE - Vice Dean for Education, Columbia University Vagelos College of Physicians and Surgeons
Jasmine Harris, JD - Professor of Law, University of Pennsylvania Carey School of Law
Vincent Marchello, MD - Chief Medical Officer and Senior Vice President, Fidelis Care
Sanjiv Shah, MD - Chief Medical Officer, MetroPlus Health
Moderated by: Johanne Morne, MS – Deputy Director for Community Health, Office of Public Health; Director, AIDS Institute and Center for Community Health, New York State Department of Health

 
Panelist Bios

 COVID-19

Accessibility

Centers for Disease Control and Prevention

Department of Health

Disclaimer

File Formats Used on this Web Site

Language Assistance

Privacy Policy

Site Map
Sobre Las Vacunas Contra El COVID-19 | Veterans Affairs
Los científicos llevan más de 20 años estudiando la tecnología de las vacunas de ARNm. Y los Institutos Nacionales de Salud (NIH) estaban trabajando en la creación de una vacuna contra el coronavirus incluso antes de la pandemia del COVID-19.Consiguieron la financiación que necesitaban para trabajar rápidamente. La pandemia del COVID-19 es una emergencia de salud pública. Así que el gobierno estadounidense invirtió millones de dólares para ayudar a estudiar y probar las vacunas.Utilizaron un proceso de revisión más rápido con todos los mismos pasos. La FDA autorizó las actuales vacunas contra el COVID-19 bajo su Autorización de Uso de Emergencia (EUA). Una EUA sigue los mismos pasos que los ensayos clínicos completos. Esto incluye probar cada vacuna en miles de participantes humanos. La única diferencia es que una EUA acelera el proceso de revisión de la FDA. Esto ayuda a que las vacunas críticas lleguen a la gente más rápidamente, al tiempo que se garantiza que las vacunas son seguras y que funcionan bien.En la revisión de los datos participaron muchos expertos. Grupos independientes también revisaron los resultados de los ensayos para asegurarse de que las vacunas son seguras. Entre ellos se encuentran grupos como la National Medical Association, la principal sociedad profesional de médicos negros.La FDA sigue supervisando las vacunas contra el COVID-19 incluso después de su aprobación.Reproduce este vídeo de la FDA para saber más sobre el proceso de la EUA (YouTube) (en inglés)
COVID-19 Forecasting and Mathematical Modeling | CDC
This article, Ensemble Forecasts of Coronavirus Disease 2019 (COVID-19) in the U.S. describes the “ensemble” forecast methodology and its usefulness as a real-time tool to help guide policy and planning.

Other Resources
COVID-19 Surge Tool


	Last Updated June 27, 2023	Source: 	National Center for Immunization and Respiratory Diseases (NCIRD), Division of Viral Diseases

Facebook
Twitter
LinkedIn
Syndicate

homeCOVID-19About COVID-19plus iconVariantsHow COVID-19 SpreadsReinfectionAnimals and COVID-19plus iconWildlifePetsToolkitHealth EquitySymptomsTestingMedical ConditionsPreventionplus iconMasksplus iconTypes of Masks and RespiratorsUse and Care of MasksHow to Use Your N95 RespiratorVentilationplus iconHome VentilationImproving Ventilation In BuildingsFacility Cleaning & Ventilationplus iconUpper-Room Ultraviolet Germicidal IrradiationVentilation in BuildingsSchool Ventilation ToolVaccinesplus iconStay Up to Date with VaccinesOverview of COVID-19 VaccinesHow COVID-19 Vaccines WorkYour Vaccinationplus iconWhen Getting Your VaccineSpecific Groups of PeopleSafety of COVID-19 Vaccinesplus iconAllergic ReactionsVaccine Safety in Children & TeensMyocarditis and PericarditisInvestigating MyocarditisReported Adverse EventsCOVID-19 Vaccine Effectivenessplus iconVaccine Effectiveness StudiesAbout COVID-19 Vaccinesplus iconFrequently Asked QuestionsBenefits of Getting VaccinatedMyths & FactsTreatments & MedicationsLong COVIDplus iconCaring for People with Long COVIDPatient Appointment TipsData & Surveillanceplus iconHospitalization Surveillance Network COVID-NETplus iconCOVID-NET DashboardCOVID-NET
People with Certain Medical Conditions | CDC
Other people have to use certain types of medicines for a long time, like corticosteroids, that weaken their immune system. One example is called primary immunodeficiency. Being immunocompromised can make you more likely to get very sick from COVID-19 or be sick for a longer period of time.
People who are immunocompromised or are taking medicines that weaken their immune system may not be protected even if they are up to date on their vaccines. Talk with your healthcare provider about what additional precautions may be necessary when respiratory viruses are causing a lot of illness in your community. Additionally, people who are moderately or severely immunocompromised may get additional doses of updated COVID-19 vaccine. Because the immune response following COVID-19 vaccination may differ in people who are moderately or severely immunocompromised, specific guidance has been developed.
People who are moderately or severely immunocompromised, are aged 12 and older, and who weigh at least 88 pounds may be eligible to get Pemivibart (Pemgarda™), a monoclonal antibody authorized to help protect against COVID-19. Pemgarda may provide another layer of protection against COVID-19 in addition to protection provided through vaccination, and can be given at least 2 weeks after receiving a COVID-19 vaccine. Pemgarda is not a treatment for COVID-19. Talk to your healthcare provider to see if Pemgarda is right for you.
Get more information:

Types of Primary Immune Deficiency Diseases
Jeffrey Modell Foundation
Immune Deficiency Foundation
Primary Immunodeficiency (PI)

Mental health conditions
Having mood disorders, including depression, and schizophrenia spectrum disorders can make you more likely to get very sick from COVID-19.
Get more information:

National Institute of Mental Health (NIMH) Shareable Resources on Coping with COVID-19
National Institute of Mental Health (NIMH) Depression
Mood Disorders

Overweight and obesity
Public Health Home
Seasonal Flu
Novel Coronavirus Disease (COVID-19)
Public Health National Program Office (PHNPO)

More Diseases »
Health & Wellness

Tobacco and Health
Vaccines and Immunization
Seasonal Flu Vaccination
Women's Health Guide
Marijuana and Health

More Health & Wellness »
Studies & Data

Epidemiology
Hepatitis Publication
HIV/AIDS Reports
New Generation Study
Public Health National Program Office (PHNPO)
VE-HEROeS Study

More Studies & Data »
Patient Treatment

Viral Hepatitis for Providers
Safe Patient Handling
Tobacco Cessation
Infection: Don't Pass It On

More Patient Treatment »
Employee Health

Employee Occupational Health
Employee Health Promotion
Workers' Compensation
Violence Prevention in Health Care Facilities

More Employee Health »
 

 

Connect with VHA

 Subscribe to Receive
 Email Updates
 

 Button to subscribe to email 

Button to subscribe to email

Health Care877-222-8387
TDD (Hearing Impaired)800-829-4833

CONNECT

 Veterans Crisis Line:
Call: 988 (Press 1)
Social Media

Complete Directory 

EMAIL UPDATES

Email Address Required

Button to subscribe to email

VA HOME

Notices
Privacy
FOIA
Regulations
Web Policies
No FEAR Act
Whistleblower Rights & Protections
Site Index
USA.gov
White House
Inspector General

QUICK LIST

Apply for Benefits
Apply for Health Care
Prescriptions
My HealtheVet
Life Insurance Online Applications
VA Forms
State and Local Resources
Strat Plan FY 2014-2020 
VA Plans, Budget, & Performance
VA Claims Representation

RESOURCES

Careers at VA
Employment Center
Returning Service Members
Vocational Rehabilitation & Employment
Homeless Veterans
Women Veterans
Minority Veterans
Plain Language
Surviving Spouses & Dependents
Adaptive Sports Program

ADMINISTRATION

Veterans Health Administration
Veterans Benefits Administration
National Cemetery Administration